SOPHiA GENETICS (SOPH) Amortization (2020)

SOPHiA GENETICS's (SOPH) quarterly Amortization came in at $3.3 billion in Q4 2020.

SOPHiA GENETICS (SOPH) Amortization (2020) Analysis & Trends

SOPHiA GENETICS has disclosed Amortization across 1 years of filings, most recently posting $3.3 billion for Q4 2020.

Amortization for Q4 2020 came in at $3.3 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $3.3 billion (changed N/A YoY), and the FY2020 annual result was $3.3 billion, changed N/A from the prior year.
Amortization came in at $3.3 billion for Q4 2020 at SOPHiA GENETICS.
In the past five years, Amortization ranged from a high of $3.3 billion in Q4 2020 to a low of $3.3 billion in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortization (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	-
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	-
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	-
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	SOPHiA GENETICS	26.19 Mn	-44.10 Mn	14.69 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	3.33 Bn
Dec 31, 2020	3.33 Bn